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Abstract 
Sarcoidosis is a multisystemic granulomatous disease of unknown etiology. Hepatic 
involvement was reported in about 11% of patients with sarcoidosis. However, cases of 
sarcoidosis in which the granuloma is solitary and limited in the liver are very rare. A 
51-year-old woman with tumors in the liver underwent extended left lobectomy with 
caudate lobectomy and bile duct resection. The tumor was located between segment 4 
and the hilar region. Some daughter nodules were found in the left lobe, which were 
regarded as intrahepatic metastasis. Our case displayed clinical and radiologically 
distinct findings, which are very similar to those of hilar cholangiocarcinoma restricted to 
the liver. This report demonstrates that sarcoidosis can show solitary hepatic 
involvement in the absence of thoracic lymphadenopathy. In such a case, it is difficult to 
distinguish the diagnosis from other malignant neoplasms. In conclusion, the diagnosis 
of hepatic sarcoidosis has to be made through prudent and comprehensive 
investigations that include a full clinical history of sarcoidosis in other organs. Despite 
utilizing several detailed diagnostic modalities, the definitive diagnosis of cases of 
solitary sarcoidosis may remain difficult. In these cases, surgical treatment including liver 
resection should be considered in order to avoid missing a suitable opportunity for 
treatment.  
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Introduction 
Sarcoidosis is a multisystemic granulomatous disease of unknown etiology 
characterized by the presence of non-caseating granuloma consisting of epithelioid cells. 
Sarcoidosis primarily affects the lung and hilar lymph nodes. Heart, spleen, bone marrow 
and less often eye, skin and salivary glands are common extrapulmonary sites of disease 
manifestation. The liver has sarcoid nodules on occasions, however these nodules are 
generally multiple and diffuse [1]. Granulomatous lesions in hepatic sarcoidosis are most 
often located at the catchment area of Glisson’s capsule. In these patients, portal 
hypertension is the predominant symptom. 
The diagnosis of hepatic sarcoidosis might be easy because patients with hepatic 
sarcoidosis have generally pulmonary lesions or hilar lymph node swelling at the same 
time. We present a case of hepatic sarcoidosis with a solitary giant nodule in the liver, but 
with radiological findings typical of hilar cholangiocarcinoma. 
Case Report 
A 51-year-old female was referred to our institution with abnormal laboratory data of liver 
function and the biliary system. She had had a light inguinal swelling lymph node for about 6 months. 
The laboratory data on admission showed slight elevation of alkaline phosphatase (ALP) and 
gamma-glutamyl transpeptidase (γ-GTP), but a normal level of tumor marker (table 1). She had no 
symptoms. Her physical condition upon admission was generally good; there was no anemia or 
jaundice, and the liver was not palpable. A swelling nodule 1.5 cm diameter was palpable at the right 
groin. 
Abdominal ultrasonography showed a low echoic lesion of 37 mm diameter with an unclear margin 
at segment 4. The intrahepatic bile ducts (IHBDs) of the left lobe were dilated to 6 mm with obstruction 
by this tumor. A swelling round lymph node of 11 mm diameter was revealed in the hilar region of the 
liver. Abdominal dynamic computed tomography (CT) revealed a 4.0 cm tumor of low density at 
segment 4, which partially invaded segments 1, 5, and 8. The tumor had poor enhancement during the 
early arterial phase (fig. 1a). During the portal in-flow phase, the tumor was detected as a low-density 
lesion with an irregular shape (fig. 1b). The contrast enhancement of the tumor was slightly intense at 
the margin of the tumor during the equilibrium phase (fig. 1c) and became more intense during the 
delayed phase, but the margin became unclear (fig. 1d). Magnetic resonance cholangiopancreatography 
showed remarkable dilatations of the IHBDs of segment 2 and 3 with an extreme stenosis of the left 
main hepatic duct. Endoscopic retrograde cholangiopancreatography also revealed conspicuous stenosis 
at the junction of the left hepatic duct and the common hepatic duct as well as stenosis and rigidity of 
the anterior and posterior branches of the right hepatic duct. Moreover, the junction of the hepatic duct 
draining the right caudate lobe had stenosis (fig. 2a). When deep cannulation was performed beyond 
the stenotic hepatic duct, dilated IHBDs of segment 2, 3 and 4 were detected. The length of the stenotic 
ducts was about 3 cm (fig. 2b). 
Extended left lobectomy with caudate lobectomy and bile duct resection was performed with a 
diagnosis of hilar cholangiocarcinoma located predominantly at the left main hepatic duct. The tumor 
occupied the region between segment 4 and the hilum. Some daughter nodules were found in the left 
lobe, which were considered to be intrahepatic metastasis. Pathological findings confirmed the presence 
of non-caseating granuloma with multinucleated giant cells. There were multiple nodules with severe 
fibrosis in the resected specimen. A lot of small non-caseating granulomas consisting of epithelioid cells 
were found in the dissected lymph nodes. The final histopathological diagnosis was hepatic sarcoidosis 
(fig. 3).  
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Discussion 
The case reported here is important because of its morphologically distinct 
characteristics from radiological findings for hepatic sarcoidosis. Sarcoidosis is a systemic 
disease that primarily affects the lungs and lymphoid tissues of the body. In Japan, 
sarcoidosis occurs mainly in the age group of 50- to 60-year-olds with a predilection for 
females [2]. Its prevalence is reported to be 1.01 per 100,000 inhabitants. 
Hepatic involvement of sarcoidosis was described in 11.5% of 736 patients in the 
ACCESS study [3]. Hepatic granulomas due to sarcoidosis were recognized most 
commonly as multiple and small nodules with less than 1.0 cm diameter. Liver 
involvement ranges from asymptomatic incidental granulomas to portal hypertension 
from granulomas in the portal triad, usually with relative preserved liver function [4]. 
Angiotensin-converting enzyme (ACE) level may be elevated in 70% of patients with 
sarcoidosis and is elevated in almost all patients with hepatic sarcoidosis. In general, in 
20–40% of patients with sarcoidosis, ALP and γ-GTP levels are elevated, but in those with 
hepatic sarcoidosis the levels are usually much higher [5]. 
Ultrasonography findings include parenchymal echogenicity, coarsening of the liver 
parenchyma with or without discrete nodules, and focal calcifications as well as contour 
irregularity [6]. On CT, hepatic granulomas are visualized as multiple, discrete, 
low-attenuating, non-contrast-enhancing nodules of variable size. As they increase in size, 
they tend to become confluent and have to be differentiated from various infectious and 
neoplasmatic conditions [7]. Magnetic resonance imaging also shows multiple diffuse, 
densely packed, uniform nodular foci with normal signal intensity with T1- and 
hypodense with T2-weighted sequence. On dynamic CT imaging, our case was 
compatible with hepatic sarcoidosis due to a poor enhancement effect on early arterial 
phase and a slight enhancement from the margin on delayed phase, even though this 
intrahepatic nodule was huge and solitary. 
In most patients with sarcoidosis, the course of hepatic involvement is asymptomatic 
[8]. In a few patients, chronic intrahepatic cholestasis or portal hypertension can 
complicate the course of the disease. Portal hypertension could be due to obstruction of 
portal flow because of granulomas in the portal area, with fibrosis and hyalinization of the 
portal triad causing presinusoidal block. Another possible mechanism was advocated in 
which there might be arteriovenous shunts that increase portal blood flow. 
Asymptomatic patients with mild elevation in liver function enzymes should not be 
treated but should be followed with serial blood work. It has been reported that the 
majority of untreated patients who are clinically asymptomatic have spontaneous 
improvement in their liver function [5]. Indeed, death from liver failure is rare. Perry and 
Vuitch reported that the mortality rate of patients with sarcoidosis was 1 of 28 at autopsy 
and 1 of 18 with portal hypertension [9]. For patients with refractory liver dysfunction, 
chronic progressive cholestatic disease and portal hypertension that develop more severe 
liver disease, corticosteroids should be administered. However, corticosteroids cannot 
prevent disease progression, including development of portal hypertension in patients 
with early or established cirrhosis [10]. For such cases, when medications are no longer 
efficacious, liver transplantation is the only option [11]. 
There are other causes of hepatic granulomas, including bacterial infections such as 
tuberculosis, brucellosis, viral infections and parasite infections, primary liver disease  
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such as primary biliary cirrhosis, autoimmune cholangiopathy and many other systemic 
illnesses. As mentioned above, there is a wide differential for granulomas in the liver. In 
western countries, a large portion is attributed to primary biliary cirrhosis (up to 55%) 
and sarcoidosis (15–30%), but infective cases, like tuberculosis and brucellosis, should 
always be kept in mind during initial investigation [12, 13]. Evaluating hepatic 
granulomas should therefore include a detailed medical and drug history followed by 
extensive laboratory testing. The majority of cases in which granulomas appear only in 
the liver are caused by liver disease rather than multisystemic disease. In that case, the 
differential diagnosis may be frequently difficult compared to other tumor-forming 
diseases, such as neoplasm in the liver. The diagnostic approach to hepatic sarcoidosis 
must be made on the histological evidence of non-caseating granulomas in a liver biopsy. 
In this report, we describe a rare experience with hepatic sarcoidosis, which 
we presented with clinical and radiological findings characteristic of hilar 
cholangiocarcinoma. We could find only two similar cases reported previously [14, 15]. 
Our experience suggests that the diagnosis of patients with tumors in the liver with 
atypical radiological findings, who have a case history of sarcoidosis, need to be 
established by comprehensive and cautious consideration. There should be no hesitation 
to perform liver biopsy if there is difficulty in making a definitive diagnosis. Despite 
utilizing several detailed and extensive diagnostic modalities, we may occasionally 
encounter a patient with a solitary tumor in the liver for whom it is extremely difficult to 
make a differential diagnosis from the malignant neoplasm, much like our experience. In 
this case, a surgical treatment including liver resection should be seriously considered, 
because a patient with hepatic sarcoidosis occasionally had to undergo liver 
transplantation in the end after a short period of observation without any treatment due 
to the difficulty of diagnosis like our case. 
Disclosure Statement 
The authors have no conflict of interest with this report. This study was not supported by any grants. 
 
 
 
Table 1. Laboratory data on admission 
WBC 5.8×10
3/˩l  Alb  4.2 g/dl  BUN  11.1 mg/dl 
RBC 4.34×10
6/˩l  T.bil  0.7 mg/dl  Cr  0.72 mg/dl 
Hb  12.8 g/dl  D.bil  0.1 mg/gl  Na  143 mEq/l 
Ht  40.0%  GOT  36 IU/l  K  3.7 mEq/l 
Plt 18.2×10
4/˩l  GPT  33 IU/l  Cl  105 mEq/l 
PT  91%  LDH  150 IU/l  ACE  19.7 IU/l 
aPTT  33.9 s  ALP  528 IU/l  HBs-Ag  (–) 
TT >100%  ˠ-GTP 356  IU/l  HCV-Ab (–) 
HPT  143%  LAP  84 IU/l  CEA  1.4 ng/ml 
FNG  395 mg/dl  ChE  4,411 IU/l  CA19-9  14.4 U/ml 
TP  8.9 g/dl  Amy  84 IU/l     
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Fig. 1. Abdominal dynamic CT. a Early arterial phase. A 4.0 cm tumor of low density with poor 
enhancement was detected at segment 4 (arrow). b Portal in-flow phase. The tumor was detected as a 
low-density lesion with an irregular shape. c Equilibrium phase. Contrast enhancement of the tumor 
was slightly intense at the margin of the tumor. d Delayed phase. Contrast enhancement became more 
intense. The margin of the tumor became unclear. 
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Fig. 2. a Endoscopic retrograde cholangiopancreatography revealing conspicuous stenosis at the 
junction of the left hepatic duct and the common hepatic duct (arrow). The right hepatic duct showed 
another stenosis and rigidity of the anterior and posterior branches (arrowheads). b The length of the 
stenotic ducts was about 3 cm (arrows). 
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Fig. 3. Histopathological findings show the presence of non-caseating granuloma with multinucleated 
giant cells, in which the final histopathological diagnosis was determined to be hepatic sarcoidosis. 
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